Peter W. Danse

1.9k total citations
55 papers, 1.1k citations indexed

About

Peter W. Danse is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter W. Danse has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Surgery, 42 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter W. Danse's work include Coronary Interventions and Diagnostics (47 papers), Cardiac Valve Diseases and Treatments (22 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Peter W. Danse is often cited by papers focused on Coronary Interventions and Diagnostics (47 papers), Cardiac Valve Diseases and Treatments (22 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Peter W. Danse collaborates with scholars based in Netherlands, Israel and Belgium. Peter W. Danse's co-authors include Clemens von Birgelen, Carine J.M. Doggen, Gerard C.M. Linssen, Martin G. Stoel, Marlies M. Kok, Marije M. Löwik, Marc Hartmann, Paolo Zocca, Carl E. Schotborgh and Liefke C. van der Heijden and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Peter W. Danse

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter W. Danse Netherlands 19 933 860 264 256 42 55 1.1k
K. Gert van Houwelingen Netherlands 18 1.1k 1.2× 858 1.0× 362 1.4× 355 1.4× 24 0.6× 57 1.2k
Knud Nørregaard Hansen Denmark 19 784 0.8× 695 0.8× 250 0.9× 319 1.2× 22 0.5× 40 1.0k
Hans‐Peter Stoll Germany 17 1.0k 1.1× 665 0.8× 480 1.8× 285 1.1× 52 1.2× 42 1.2k
Marlies M. Kok Netherlands 16 748 0.8× 643 0.7× 233 0.9× 195 0.8× 22 0.5× 40 898
Marco Bressers Netherlands 13 797 0.9× 597 0.7× 274 1.0× 391 1.5× 35 0.8× 16 887
Martin G. Stoel Netherlands 22 1.5k 1.6× 1.4k 1.6× 400 1.5× 711 2.8× 56 1.3× 77 1.9k
Muzaffer Değertekin Türkiye 11 703 0.8× 708 0.8× 218 0.8× 313 1.2× 34 0.8× 31 995
Patrick Serruys Netherlands 11 798 0.9× 575 0.7× 254 1.0× 559 2.2× 39 0.9× 14 966
Simon Elhadad France 12 711 0.8× 1.0k 1.2× 99 0.4× 297 1.2× 65 1.5× 33 1.1k
Douglas Spriggs United States 7 1.3k 1.4× 1.5k 1.8× 362 1.4× 388 1.5× 39 0.9× 10 1.9k

Countries citing papers authored by Peter W. Danse

Since Specialization
Citations

This map shows the geographic impact of Peter W. Danse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Danse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Danse more than expected).

Fields of papers citing papers by Peter W. Danse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Danse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Danse. The network helps show where Peter W. Danse may publish in the future.

Co-authorship network of co-authors of Peter W. Danse

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Danse. A scholar is included among the top collaborators of Peter W. Danse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Danse. Peter W. Danse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ploumen, Eline H., Rosaly A. Buiten, Carine J.M. Doggen, et al.. (2024). Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years. PharmacoEconomics - Open. 9(1). 137–145. 1 indexed citations
3.
Ploumen, Eline H., Marlies M. Kok, Carl E. Schotborgh, et al.. (2024). Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease. Cardiovascular Intervention and Therapeutics. 40(2). 287–295. 1 indexed citations
4.
Ploumen, Eline H., Carine J.M. Doggen, Carl E. Schotborgh, et al.. (2024). Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials. Netherlands Heart Journal. 32(6). 254–261. 1 indexed citations
5.
Oord, Stijn C.H. van den, Marleen van Wely, Peter W. Danse, et al.. (2022). Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre Registry. Journal of Interventional Cardiology. 2022. 1–7. 8 indexed citations
6.
Ploumen, Eline H., Rosaly A. Buiten, Paolo Zocca, et al.. (2022). Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers. Journal of the American Heart Association. 11(22). e026041–e026041. 15 indexed citations
7.
Timmermans, Marijke, et al.. (2022). Using real-world data to monitor and improve quality of care in coronary artery disease: results from the Netherlands Heart Registration. Netherlands Heart Journal. 30(12). 546–556. 36 indexed citations
8.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2019). Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents. JACC: Cardiovascular Interventions. 12(17). 1650–1660. 40 indexed citations
9.
10.
Kok, Marlies M., Clemens von Birgelen, Naveed Sattar, et al.. (2018). Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention. 14(9). e1049–e1056. 35 indexed citations
11.
Zocca, Paolo, Marlies M. Kok, Kenneth Tandjung, et al.. (2018). 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents. JACC: Cardiovascular Interventions. 11(5). 462–469. 34 indexed citations
12.
13.
Heijden, Liefke C. van der, Marlies M. Kok, Paolo Zocca, et al.. (2017). Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial. American Heart Journal. 198. 25–32. 6 indexed citations
14.
Kok, Marlies M., Liefke C. van der Heijden, Hanim Sen, et al.. (2016). Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents. JACC: Cardiovascular Interventions. 9(6). 553–561. 10 indexed citations
15.
Heijden, Liefke C. van der, Marlies M. Kok, Hans W. Louwerenburg, et al.. (2016). Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes. Journal of Cardiology. 69(4). 660–665. 20 indexed citations
16.
Sen, Hanim, Ming Kai Lam, Marije M. Löwik, et al.. (2015). Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents. JACC: Cardiovascular Interventions. 8(7). 889–899. 34 indexed citations
17.
Heijden, Liefke C. van der, Marlies M. Kok, Ming Kai Lam, et al.. (2015). Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clinical Research in Cardiology. 105(3). 206–215. 9 indexed citations
18.
19.
Hartmann, Marc, Gert K. van Houwelingen, Frits H.A.F. de Man, et al.. (2008). Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo. International journal of cardiac imaging. 25(1). 13–23. 24 indexed citations
20.
Duytschaever, Mattias, et al.. (2002). Is There an Optimal Pacing Site to Prevent Atrial Fibrillation?: An Experimental Study in the Chronically Instrumented Goat. Journal of Cardiovascular Electrophysiology. 13(12). 1264–1271. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Gert van Houwelingen Breakdown of academic impact, for papers by Knud Nørregaard Hansen Breakdown of academic impact, for papers by Hans‐Peter Stoll Breakdown of academic impact, for papers by Marlies M. Kok Breakdown of academic impact, for papers by Marco Bressers Breakdown of academic impact, for papers by Martin G. Stoel Breakdown of academic impact, for papers by Muzaffer Değertekin Breakdown of academic impact, for papers by Patrick Serruys Breakdown of academic impact, for papers by Simon Elhadad Breakdown of academic impact, for papers by Douglas Spriggs
Rankless by CCL
2026